GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (OTCPK:EKDHF) » Definitions » EV-to-EBIT

EKF Diagnostics Holdings (EKF Diagnostics Holdings) EV-to-EBIT : 55.22 (As of Apr. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is EKF Diagnostics Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, EKF Diagnostics Holdings's Enterprise Value is $154.23 Mil. EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2.79 Mil. Therefore, EKF Diagnostics Holdings's EV-to-EBIT for today is 55.22.

The historical rank and industry rank for EKF Diagnostics Holdings's EV-to-EBIT or its related term are showing as below:

EKDHF' s EV-to-EBIT Range Over the Past 10 Years
Min: -1674.19   Med: 9.98   Max: 114.67
Current: 55.9

During the past 13 years, the highest EV-to-EBIT of EKF Diagnostics Holdings was 114.67. The lowest was -1674.19. And the median was 9.98.

EKDHF's EV-to-EBIT is ranked worse than
85.53% of 463 companies
in the Medical Devices & Instruments industry
Industry Median: 19.98 vs EKDHF: 55.90

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. EKF Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $141.02 Mil. EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2.79 Mil. EKF Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.98%.


EKF Diagnostics Holdings EV-to-EBIT Historical Data

The historical data trend for EKF Diagnostics Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings EV-to-EBIT Chart

EKF Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.87 19.67 15.23 -25.00 64.73

EKF Diagnostics Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.23 - -25.00 - 64.73

Competitive Comparison of EKF Diagnostics Holdings's EV-to-EBIT

For the Medical Devices subindustry, EKF Diagnostics Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKF Diagnostics Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's EV-to-EBIT falls into.



EKF Diagnostics Holdings EV-to-EBIT Calculation

EKF Diagnostics Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=154.232/2.793
=55.22

EKF Diagnostics Holdings's current Enterprise Value is $154.23 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKF Diagnostics Holdings  (OTCPK:EKDHF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

EKF Diagnostics Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=2.793/141.0241761
=1.98 %

EKF Diagnostics Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $141.02 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKF Diagnostics Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


EKF Diagnostics Holdings (EKF Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (EKF Diagnostics Holdings) Headlines

From GuruFocus